Dr. Loan K Dao

D.D.S. | Dentist



  
  455 W Foothill Blvd, Glendora
  California, 91741-3363

  626-914-9808    626-914-9808 Maps & Directions
Dr. Loan K Dao is a Glendora, California based Dentist who is specialized in Dentistry. She may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. Her current practice location is 455 W Foothill Blvd, Glendora. Patients can reach her at 626-914-9808.
Dr. Loan K Dao is the primary dental care provider for patients of all ages. She is responsible for the diagnosis, treatment, management and overall coordination of services related to patients' oral health needs.
Complete Profile:
Dr. Loan K Dao speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Name: Dr. Loan K Dao
Specialization: Dentist
Gender:Female
Credentials: D.D.S.
Accepts Medicare Assignment:May Accept
Practice Address:455 W Foothill Blvd, Glendora,
California, 91741-3363
Phone:626-914-9808
Fax:626-914-9808
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
PAC ID: 2769784388
Enrollment ID: I20160113001326
NPI Number: 1730379314
NPI Enumeration Date: 30 Jul, 2007
NPI Last Update On: 10 Oct, 2014

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 455 W Foothill Blvd,
Glendora, California
Zip: 91741-3363
Phone Number: 714-878-7748
Fax Number: 714-891-0685
Patients can reach Dr. Loan K Dao at 455 W Foothill Blvd, Glendora, California or can call to book an appointment on 626-914-9808. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.

Comments/ Reviews: